214 related articles for article (PubMed ID: 28911138)
1. Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion.
Debono M; Harrison RF; Chadarevian R; Gueroult C; Abitbol JL; Newell-Price J
J Clin Endocrinol Metab; 2017 Sep; 102(9):3461-3469. PubMed ID: 28911138
[TBL] [Abstract][Full Text] [Related]
2. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.
Ceccato F; Barbot M; Albiger N; Antonelli G; Zilio M; Todeschini M; Regazzo D; Plebani M; Lacognata C; Iacobone M; Mantero F; Boscaro M; Scaroni C
Endocrine; 2018 Mar; 59(3):510-519. PubMed ID: 28956262
[TBL] [Abstract][Full Text] [Related]
3. Limited Role of Hair Cortisol and Cortisone Measurement for Detecting Cortisol Autonomy in Patients With Adrenal Incidentalomas.
Puglisi S; Leporati M; Amante E; Parisi A; Pia AR; Berchialla P; Terzolo M; Vincenti M; Reimondo G
Front Endocrinol (Lausanne); 2022; 13():833514. PubMed ID: 35222288
[TBL] [Abstract][Full Text] [Related]
4. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
[TBL] [Abstract][Full Text] [Related]
5. Adrenal incidentaloma as a novel independent predictive factor for periodontitis.
Rodrigues MO; Moraes AB; de Paula MP; Pereira VA; Leão ATT; Vieira Neto L
J Endocrinol Invest; 2021 Nov; 44(11):2455-2463. PubMed ID: 33788166
[TBL] [Abstract][Full Text] [Related]
6. Depression: another cortisol-related comorbidity in patients with adrenal incidentalomas and (possible) autonomous cortisol secretion.
Šojat AS; Dunjić-Kostić B; Marina LV; Ivović M; Radonjić NV; Kendereški A; Ćirković A; Tančić-Gajić M; Arizanović Z; Mihajlović S; Vujović S
J Endocrinol Invest; 2021 Sep; 44(9):1935-1945. PubMed ID: 33528757
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients' stratification by body mass index and age.
Podbregar A; Janez A; Goricar K; Jensterle M
BMC Endocr Disord; 2020 Jul; 20(1):118. PubMed ID: 32736549
[TBL] [Abstract][Full Text] [Related]
8. The activity of 11β-hydroxysteroid dehydrogenase type 2 enzyme and cortisol secretion in patients with adrenal incidentalomas.
Morelli V; Polledri E; Mercadante R; Zhukouskaya V; Palmieri S; Beck-Peccoz P; Spada A; Fustinoni S; Chiodini I
Endocrine; 2016 Sep; 53(3):809-15. PubMed ID: 26438395
[TBL] [Abstract][Full Text] [Related]
9. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
Falcetta P; Orsolini F; Benelli E; Agretti P; Vitti P; Di Cosmo C; Tonacchera M
Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435
[TBL] [Abstract][Full Text] [Related]
10. Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma.
Yener S; Genc S; Akinci B; Secil M; Demir T; Comlekci A; Ertilav S; Yesil S
Endocrine; 2009 Jun; 35(3):365-70. PubMed ID: 19277910
[TBL] [Abstract][Full Text] [Related]
11. Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study.
Debono M; Chadarevian R; Eastell R; Ross RJ; Newell-Price J
PLoS One; 2013; 8(4):e60984. PubMed ID: 23577182
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
Daniel E; Aylwin S; Mustafa O; Ball S; Munir A; Boelaert K; Chortis V; Cuthbertson DJ; Daousi C; Rajeev SP; Davis J; Cheer K; Drake W; Gunganah K; Grossman A; Gurnell M; Powlson AS; Karavitaki N; Huguet I; Kearney T; Mohit K; Meeran K; Hill N; Rees A; Lansdown AJ; Trainer PJ; Minder AE; Newell-Price J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4146-54. PubMed ID: 26353009
[TBL] [Abstract][Full Text] [Related]
13. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
[TBL] [Abstract][Full Text] [Related]
14. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
[TBL] [Abstract][Full Text] [Related]
15. Salivary Cortisone to Estimate Cortisol Exposure and Sampling Frequency Required Based on Serum Cortisol Measurements.
Harrison RF; Debono M; Whitaker MJ; Keevil BG; Newell-Price J; Ross RJ
J Clin Endocrinol Metab; 2019 Mar; 104(3):765-772. PubMed ID: 30285244
[TBL] [Abstract][Full Text] [Related]
16. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
Papanastasiou L; Alexandraki KI; Androulakis II; Fountoulakis S; Kounadi T; Markou A; Tsiavos V; Samara C; Papaioannou TG; Piaditis G; Kaltsas G
Clin Endocrinol (Oxf); 2017 Apr; 86(4):488-498. PubMed ID: 27992961
[TBL] [Abstract][Full Text] [Related]
17. Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients.
Young EA; Haskett RF; Grunhaus L; Pande A; Weinberg VM; Watson SJ; Akil H
Arch Gen Psychiatry; 1994 Sep; 51(9):701-7. PubMed ID: 8080346
[TBL] [Abstract][Full Text] [Related]
18. Performance of DHEAS as a Screening Test for Autonomous Cortisol Secretion in Adrenal Incidentalomas: A Prospective Study.
Liu MS; Lou Y; Chen H; Wang YJ; Zhang ZW; Li P; Zhu DL
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1789-e1796. PubMed ID: 35137142
[TBL] [Abstract][Full Text] [Related]
19. Stimulated Salivary Cortisol as a Noninvasive Diagnostic Tool for Adrenal Insufficiency.
Kim YJ; Kim JH; Hong AR; Park KS; Kim SW; Shin CS; Kim SY
Endocrinol Metab (Seoul); 2020 Sep; 35(3):628-635. PubMed ID: 32981305
[TBL] [Abstract][Full Text] [Related]
20. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
Ross IL; Lacerda M; Pillay TS; Blom DJ; Johannsson G; Dave JA; Levitt NS; Haarburger D; van der Walt JS
Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
